DIVISLAB.NS Balance Sheet
Divi's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹4,714.17 Cr. | ₹4,733.00 Cr. | ₹5,437.00 Cr. | ₹6,515.00 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹211.88 Cr. | ₹778.00 Cr. | ₹1,022.00 Cr. | ₹2,113.00 Cr. | CapitalWorkInProgress |
| Goodwill | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | Goodwill |
| Other Intangible Assets | ₹8.43 Cr. | ₹6.00 Cr. | ₹4.00 Cr. | ₹13.00 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹77.05 Cr. | ₹82.00 Cr. | ₹65.00 Cr. | ₹69.00 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹50.17 Cr. | ₹130.00 Cr. | ₹250.00 Cr. | ₹146.00 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹5,127.03 Cr. | ₹5,795.00 Cr. | ₹6,851.00 Cr. | ₹8,937.00 Cr. | NoncurrentAssets |
| Inventories | ₹3,000.41 Cr. | ₹3,184.00 Cr. | ₹3,236.00 Cr. | ₹3,954.00 Cr. | Inventories |
| Trade Receivables | ₹1,792.53 Cr. | ₹2,156.00 Cr. | ₹2,731.00 Cr. | ₹2,984.00 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹169.70 Cr. | ₹363.00 Cr. | ₹415.00 Cr. | ₹128.00 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹299.64 Cr. | ₹348.00 Cr. | ₹383.00 Cr. | ₹736.00 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹9,311.74 Cr. | ₹9,675.00 Cr. | ₹10,081.00 Cr. | ₹11,096.00 Cr. | CurrentAssets |
| Total Assets | ₹14,438.77 Cr. | ₹15,470.00 Cr. | ₹16,932.00 Cr. | ₹20,033.00 Cr. | Assets |
| Equity Share Capital | ₹53.09 Cr. | ₹53.00 Cr. | ₹53.00 Cr. | ₹53.00 Cr. | EquityShareCapital |
| Other Equity | ₹12,714.00 Cr. | ₹13,518.00 Cr. | ₹14,916.00 Cr. | ₹16,708.00 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹12,767.09 Cr. | ₹13,571.00 Cr. | ₹14,969.00 Cr. | ₹16,761.00 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | NonControllingInterest |
| Total Equity | ₹12,767.09 Cr. | ₹13,571.00 Cr. | ₹14,969.00 Cr. | ₹16,761.00 Cr. | Equity |
| Long-term Borrowings | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹570.60 Cr. | ₹621.00 Cr. | ₹511.00 Cr. | ₹1,229.00 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹0.00 Cr. | ₹0.00 Cr. | ₹2.00 Cr. | ₹0.00 Cr. | BorrowingsCurrent |
| Trade Payables | ₹762.51 Cr. | ₹824.00 Cr. | ₹910.00 Cr. | ₹1,211.00 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹287.56 Cr. | ₹303.00 Cr. | ₹352.00 Cr. | ₹298.00 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹1,101.08 Cr. | ₹1,278.00 Cr. | ₹1,452.00 Cr. | ₹2,043.00 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹14,438.77 Cr. | ₹15,470.00 Cr. | ₹16,932.00 Cr. | ₹20,033.00 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from DIVISLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).